MET transcriptional regulator/serine peptidase inhibitor kunitz type 1 panel operating through HGF/c‐MET axis as a prognostic signature in pan‐cancer
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.3834
Abstract: Dysregulations in transcription factors (TFs) and their genetic products play important roles in tumorigenesis, tumor progression and metastasis. However, prognostic value of the transcriptional regulatory networks in different cancers has not been investigated in depth.… read more here.
Keywords: met transcriptional; hgf met; signature; cancer ... See more keywords
Ezrin mediates both HGF/Met autocrine and non‐autocrine signaling‐induced metastasis in melanoma
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31196
Abstract: Aberrant HGF/Met signaling promotes tumor migration, invasion, and metastasis through both autocrine and non‐autocrine mechanisms; however, the molecular downstream signaling mechanisms by which HGF/Met induces metastasis are incompletely understood. We here report that Ezrin expression… read more here.
Keywords: autocrine; non autocrine; hgf met; metastasis ... See more keywords
HGF/c‐Met Promotes Breast Cancer Tamoxifen Resistance Through the EZH2/HOTAIR‐miR‐141/200a Feedback Signaling Pathway
Sign Up to like & getrecommendations! Published in 2025 at "Molecular Carcinogenesis"
DOI: 10.1002/mc.23878
Abstract: Tamoxifen is one of the most frequently used endocrine medications for the treatment of estrogen receptor‐positive (ER + ) breast cancer (BC). Unfortunately, tamoxifen resistance (TR) brings more challenges to the clinical treatment, and the mechanisms of… read more here.
Keywords: cancer; hotair; 141 200a; mir 141 ... See more keywords
Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression
Sign Up to like & getrecommendations! Published in 2020 at "Medical Oncology"
DOI: 10.1007/s12032-020-01350-4
Abstract: Lenvatinib is a long-awaited alternative to sorafenib for the first-line targeted therapy of patients with advanced hepatocellular carcinoma (HCC). However, resistance to lenvatinib has also become a major obstacle to improving the prognosis of HCC… read more here.
Keywords: hcc; met expression; hgf met; lenvatinib resistance ... See more keywords
Sevoflurane preconditioning activates HGF/Met-mediated autophagy to attenuate hepatic ischemia-reperfusion injury in mice.
Sign Up to like & getrecommendations! Published in 2021 at "Cellular signalling"
DOI: 10.1016/j.cellsig.2021.109966
Abstract: Sevoflurane (SEV) preconditioning plays a protective effect against liver ischemia reperfusion (IR) injury, while the role of autophagy in SEV-mediated hepatoprotection and the precise mechanism is unclear. In the current study, mice were pretreated with… read more here.
Keywords: hgf met; autophagy; mice; ischemia reperfusion ... See more keywords
YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/0008-5472.can-20-0242
Abstract: YAP-dependent changes of the liver vascular niche comprise the formation of heterologous communication hubs in which tumor cell-derived factors modify the cross-talk between EC subpopulations. The oncogene yes-associated protein (YAP) controls liver tumor initiation and… read more here.
Keywords: hgf met; communication; vascular niche; cell ... See more keywords
Abstract 6658: Inhibiting glycolysis for the treatment of HGF/MET/TWIST1 driven NSCLC brain metastases
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-6658
Abstract: Non-small cell lung cancer (NSCLC) has the highest incidence of brain metastases (BM), with ∼40% of patients developing BM. We identified a significant enrichment of MET amplification (amp) in NSCLC BM compared to primary lung… read more here.
Keywords: brain; glycolysis; sensitivity; driven nsclc ... See more keywords
Hypoxic stress disrupts HGF/Met signaling in human trophoblasts: implications for the pathogenesis of preeclampsia
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Biomedical Science"
DOI: 10.1186/s12929-022-00791-5
Abstract: Background Preeclampsia (PE), a placenta-associated pregnancy complication, is the leading cause of maternal and perinatal morbidity and mortality. Met/Erk signaling is inhibited in the placentas of patients with early-onset preeclampsia (E-PE), but the underlying mechanisms… read more here.
Keywords: hgf met; endocytosis; met signaling; pathogenesis preeclampsia ... See more keywords
The HGF-MET signaling pathway is enriched in LUAC brain metastases.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e20597
Abstract: e20597 Background: Brain metastases occur in over 40% of non-small cell lung cancer (NSCLC) patients leading to a poor prognosis. c-Met (MET) is a receptor tyrosine kinase that upon binding hepatocyte growth factor (HGF), mediates… read more here.
Keywords: luac brain; hgf met; primary luac; brain metastases ... See more keywords
HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
Sign Up to like & getrecommendations! Published in 2019 at "OncoTargets and therapy"
DOI: 10.2147/ott.s217595
Abstract: Background HGF/MET has been found to be associated with non-small cell lung cancer (NSCLC). However, the underlying molecular mechanisms of HGF/MET involved in regulating the metastasis of NSCLC remain unclear. Methods The effect of HGF/MET… read more here.
Keywords: small cell; hgf met; metastasis; non small ... See more keywords
The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-220871
Abstract: An estimated 6.5 million Americans aged 65 years or older have Alzheimer’s disease (AD), which will grow to 13.8 million Americans by 2060. Despite the growing burden of dementia, no fundamental change in drug development… read more here.
Keywords: hgf met; case novel; disease; dementia ... See more keywords